| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |